Няма намерени резултати



Cardiotocography (CTG) is the "gold standard" for fetal monitoring of low- and high-risk pregnancies in late gestation.


It is used to better understand and assess the fetal condition in utero and is believed to reduce the risk of stillbirth.


Cardiotocography has practically no contraindications. The method is non-invasive, sufficiently informative and well-accepted by most pregnant ladies.


Due to the possibility of compression of the inferior vena cava during the examination, it is necessary to perform the recording in the left lateral position in selected cases .



Indirect cardiotocography (CTG) is usually performed at MC MARKOVS as follows:

  • In low-risk pregnancies we start with CTG from 32 weeks of gestation (w.g.) once every 2 weeks (or more often in indicated) until 37 w.g. After that, weekly CTG monitoring is continued until delivery;
  • In high-risk pregnancies (i.e. with arterial hypertension, preeclampsia, diabetes mellitus, intrauterine fetal retardation, etc.), CTG follow-up normally begins at 30 w.g. or earlier, once per week (or more often if indicated);
  • CTG can be performed at any gestationl age with a viable fetus prenatally diagnosed with an associated structural abnormality that requires intensive neonatal care after delivery;
  • CTG monitoring is an important component of the fetal biophysical profile (BPH);
  • If required by your attending physician.

We offer to all our patients MC MARKOVS the full range of tests for thorough in utero assessment of the fetal well-being - indirect cardiotocography (CTG) with the recording of uterine contractions (the so-called Non Stress Test), biophysical profile (basic and extended), Doppler ultrasound etc.


The type and method of fetal monitoring is determined by your obstetrician-gynecologist. All tests are performed in a comfortable environment with quality equipment by highly qualified Ob&Gyne specialists.


For more information you can contact your doctor or call at the registration desk.